Skip to content

PTSD: all studies

Page 6 of 210: studies 51 to 60 of 2,096, newest first. Back to the PTSD overview

Research

Ketamine-assisted psychotherapy for treatment of an Asian American patient with post-traumatic stress disorder (PTSD): a case study

Psychiatry Research Case Reports May 22, 2026 Albert Yeung, Huiqiong Deng, Wendy Feng et al.

Background Posttraumatic stress disorder (PTSD) remains a challenging condition to treat. Nonpsychedelic pharmacotherapies have modest efficacy, and trauma-focused therapies such as Cognitive Behavioral Therapy (CBT) and Eye Movement Desensitization and Reprocessing (EMDR) demonstrate higher response rates than medications, yet they suffer from high dropout rates (25–35%) and limited...

DOI: 10.1016/j.psycr.2026.100331 (opens in new tab) Asian americans Depression economics Stress linguistics Medline +2

Psychedelic Strawmen: A Call for Greater Transparency of PTSD Treatment Efficacy in Psychedelic-Assisted Therapy Research

Current Treatment Options in Psychiatry May 14, 2026 Deidre A. Marsh, Edwin Bacalso

Abstract Psychedelic-assisted therapy (PAT) is a novel and promising form of treatment for posttraumatic stress disorder (PTSD). However, clinicians may experience challenges in interpreting the existing evidence for PAT to make informed decisions about treatment recommendations and selection with their patients. Prior commentators have noted the hype surrounding public discussions of PAT. This...

Effectiveness of guided imagery to improve sleep quality among young adults with post-traumatic stress disorder (PTSD)

Journal of Associated Medical Sciences May 2, 2026 G Vikraman, Benitta Paulin Giftlin R.

Background: Post-traumatic stress disorder often leads to ongoing sleep difficulties such as insomnia and nightmares, which can interfere with mood, concentration, and daily activities. Guided imagery, a relaxation method that uses calming, multisensory visualizations, has shown potential to improve sleep and reduce distress in people experiencing high stress or trauma. This study evaluates the...

1056 Targeted Dream Incubation’s Impact on Dream Self-Efficacy, Nightmares, Suicide, PTSD, and Insomnia

Sleep May 1, 2026 Westley Youngren, Victoria West Staples, Emma Angle et al.

Abstract Introduction Targeted Dream Incubation (TDI) is the process of giving an individual auditory cues (i.e., “think of a tree”) while they are falling asleep, with the goal of shaping dream content (into something such as a tree). Recent research has demonstrated TDI may be able to increase dream self-efficacy (DSE) and influence other mental health outcomes. Thus, our study explored how...

0123 Large Language Model-Derived Dream Affect is a Prospective Predictor of PTSD Symptoms in Hospitalized Trauma Patients

Sleep May 1, 2026 Holland Doise, A. Gonzalez Quesada, Garrett Baber et al.

Abstract Introduction Nightmares are associated with more severe posttraumatic stress disorder (PTSD). The advent of large language models (LLM) offers unique advantages to efficiently code affective dream content over human methods, which can be resource intensive and prone to error. This study tested whether dream affect (DA), measured via self-report, human-rated narrative coding, and LLM...

Efficacy and Safety of the Neuroplastogen TSND-201 for the Treatment of PTSD: A Randomized Clinical Trial.

JAMA Psychiatry May 1, 2026 Amanda Jones, Jennifer Warner-Schmidt, Hannah Kwak et al. 6 citations

The phase 2 data presented here support the development of TSND-201 for posttraumatic stress disorder (PTSD), a disorder for which there is a significant unmet need for rapid-acting and effective treatments. TSND-201 (methylone) is a highly selective, rapid-acting neuroplastogen that releases serotonin, norepinephrine, and dopamine without direct activity at 5-hydroxytryptamine (5-HT) 2A...

Methylone demonstrates improvement in PTSD symptoms in Phase 2 study

The Brown University Psychopharmacology Update April 30, 2026

Four weekly doses of TSND‐201 (methylone), an analog of 3,4 methylenedioxymethamphetamine (MDMA), resulted in significant improvement relative to placebo in reducing symptoms of post‐traumatic stress disorder (PTSD), a Phase 2 study has found. Treatment‐emergent adverse events associated with TSND‐201 were generally mild to moderate in severity, with no significant suicidal ideation. Study...

DOI: 10.1002/pu.31448 (opens in new tab) Placebo Adverse effect Phase matter Posttraumatic stress +1

Assessing Sleep Disturbance in PTSD: Nightmares, Awakenings, and Sleep Terrors

April 28, 2026 David Osser

When assessing sleep disturbances in PTSD, count disturbed awakenings as nightmares at baseline. This is a key symptom of PTSD-related sleep problems and a target for treatment. Investigate nicotine withdrawal in pack-a-day smokers who awaken after several hours. An important indicator is the patient’s ability to return to sleep after smoking a cigarette. For sleep terrors with thrashing and...

Media hype regarding psychedelic treatments for depression and PTSD from 2017 to 2024

Scientific Reports April 25, 2026 Audrey G. Evers, Elizabeth C. Stade, Aadesh Salecha et al. 1 citation

Enthusiastic media coverage of psychedelics as a treatment for mental health disorders is perceived as hyped compared to coverage of established treatments. To measure potential hype, we conducted pre-registered analyses comparing media coverage (e.g., newspaper articles) of psychedelics to FDA-approved antidepressants for major depressive disorder and posttraumatic stress disorder. We used...

DOI: 10.1038/s41598-026-50186-x (opens in new tab) Full text (opens in new tab) Anxiety Depression economics Media coverage Mental health +9

REDUCTION IN SYMPTOMS OF POSTTRAUMATIC STRESS DISORDER AND DEPRESSION IN UKRAINIAN REFUGEES PRACTICING TRANSCENDENTAL MEDITATION

Clinical and Preventive Medicine April 20, 2026 Mykola Didukh, K. Freytag, Vitalii Lunov et al.

Introduction. Following the full-scale Russian invasion of Ukraine, there has been a substantial increase in the need for accessible, rapid-acting, and non-pharmacological approaches to alleviate symptoms of post-traumatic stress disorder and depression among Ukrainian refugees. One potentially useful intervention is the Transcendental Meditation program. Aim. To assess the effectiveness of the...

DOI: 10.31612/2616-4868.2.2026.07 (opens in new tab) Major depressive disorder Transcendental meditation Depression economics Intervention counseling +5